Articles on pramipexole from NPS RADARArticles on pramipexole from NPS RADAR

(pram-i-PECKS-ole)
Title Content Type Date Description
PBS listing of extended-release pramipexole (Sifrol ER) for Parkinson’s disease Professional publication - NPS RADAR - Brief item 2010-08-01 00:00:00 An extended-release formulation of pramipexole (Sifrol ER) has been listed on the PBS for treating Parkinson’s disease.
Immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinson’s disease Professional publication - NPS RADAR - Review 2010-08-01 00:00:00 Pramipexole is a non-ergot dopamine agonist for treating early Parkinson’s disease. Sleep attacks and compulsive behaviour have been reported with pramipexole and other dopamine agonists
Pramipexole (Sifrol) for severe primary restless legs syndrome Professional publication - NPS RADAR - Review 2009-04-01 00:00:00 Pramipexole may be useful for people with diagnosed restless legs syndrome who have daily symptoms, when non-drug measures prove ineffective. It can cause sudden-onset daytime sleep, and rare cases of compulsive behaviour have been reported.

NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.

Date published: 2009-10-30 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.